Shareholders of Walgreens Boots Alliance, Inc. Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - WBA — Neutral
WBA Accesswire — February 17, 2025NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=130089&wire=1 or contact Joseph E. Levi, Esq.
Meta's global affairs chief highlights Trump as its possible new defender against EU regulators — Neutral
META Business Insider — February 17, 2025Meta's policy chief said the company would loop in Trump when it feels targeted by regulators abroad. The company believes Trump would defend US companies he views as being treated unfairly.
IAMGOLD Gears Up to Report Q4 Earnings: What's in Store? — Positive
IAG Zacks Investment Research — February 17, 2025IAG's Q4 results are likely to reflect higher gold prices and production.
Meta plans to build world's longest underwater sub-sea cable venture — Positive
META The Guardian — February 17, 2025Project Waterworth involves 50,000km cable using 24 fibre-pair system connecting US, India, Brazil and other regions
SPXL: The Market-Beating Strategy For Positive Risk-Adjusted Returns — Positive
SPXL Seeking Alpha — February 17, 2025Buying SPXL when SPY is above its 200-day moving average produces positive risk-adjusted returns. The strategy beats the market over the long term. For this strategy to work, an investor has to pick an index that has a solid return/risk ratio.
Southern Copper Q4 Earnings Miss Estimates, Sales Rise Y/Y — Negative
SCCO Zacks Investment Research — February 17, 2025SCCO's reports record revenues in 2024, backed by higher sales volumes.
Hecla Mining Q4 Earnings Meet Estimates, Revenues Rise 55% Y/Y — Positive
HL Zacks Investment Research — February 17, 2025HL reports record 2024 revenues, backed by higher gold prices.
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK — Neutral
MRK Accesswire — February 17, 2025NEW YORK, NY / ACCESS Newswire / February 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
Inflationary Pressures: Not All That Glitters Is Gold — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL See It Market — February 17, 2025The usual spin on why you should own some commodity exposure in a diversified portfolio is pretty standard – a little bit of diversification but most importantly, inflation protection. Looking at the past five years, that certainly adds up.
Zeta Global: A Massive Move Expected After Earnings, I See Upside Ahead — Positive
ZETA Seeking Alpha — February 17, 2025AI remains a hot topic, with major firms investing heavily, but small caps like Zeta Global face valuation challenges and competition. Despite past controversies, I maintain a buy rating on ZETA, driven by strong revenue growth, political ad spending, and positive free cash flow. ZETA's Q4 earnings report is expected to be volatile, with significant market movement anticipated; investors should position size appropriately.
Gold is not overbought in the long term - NDR's Tim Hayes — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — February 17, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Looming Challenges, But Kenvue Could Become A Compelling Dividend Growth Stock Beyond 2025 — Positive
KVUE Seeking Alpha — February 17, 2025Kenvue, spun off from Johnson & Johnson, shows potential as a solid dividend stock post-2025 despite current economic challenges and recent earnings misses. The company boasts strong brands like Tylenol and Listerine, and management's cost-cutting initiatives aim to save $350 million by 2026. Kenvue's valuation and growth prospects make it attractive for long-term dividend investors, but cash flow headwinds warrant a hold rating for now.
Marex Group plc to Announce Fourth Quarter and Full Year 2024 Results on March 6, 2025 with an Investor Day on April 2, 2025 — Neutral
MRX GlobeNewsWire — February 17, 2025NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (NASDAQ: MRX) today announced that it will release its 2024 fourth quarter and full year results before market open on Thursday, March 6, 2025. The earnings release and supplementary materials will be available through the "Investors" section of the Marex website at https://ir.marex.com/.
Cameco Gears Up to Report Q4 Earnings: What's in Store? — Positive
CCJ Zacks Investment Research — February 17, 2025CCJ's Q4 results are likely to reflect the impacts of higher uranium sales volumes, somewhat offset by lower prices.
ITIC's Q4 Earnings Rise Y/Y in Q4 on Lower Rates, Stock Up 2% — Positive
ITIC Zacks Investment Research — February 17, 2025Investors Title posts strong Q4 earnings, driven by higher premiums and lower mortgage rates, despite an elevated expense level.
Scripps Howard Fund and Scripps Howard Foundation gave $9.8 million in charitable gifts in 2024 — Neutral
SSP PRNewsWire — February 17, 2025CINCINNATI , Feb. 17, 2025 /PRNewswire/ -- The Scripps Howard Fund and Scripps Howard Foundation, nonprofit organizations, awarded $9.8 million to community and journalism programs during 2024, a nearly 10% increase from 2023. The Scripps Howard Fund and Scripps Howard Foundation support communities where The E.W.
MiT's Q2 Loss Narrows Y/Y as Cinema Recovery Gains Steam, Stock Up 1% — Positive
MITQ Zacks Investment Research — February 17, 2025MITQ incurs a narrower year-over-year loss in fiscal Q2 and also posts revenue growth as industry demand rebounds, driven by a cinema technology upgrade cycle and stronger customer spending.
3 Reasons Why Acuity Brands (AYI) Is a Great Growth Stock — Positive
AYI Zacks Investment Research — February 17, 2025Acuity Brands (AYI) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Growth Investors Will Love Cambium (CMBM) — Positive
CMBM Zacks Investment Research — February 17, 2025Cambium (CMBM) possesses solid growth attributes, which could help it handily outperform the market.
